These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 24594358)
1. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation. Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358 [TBL] [Abstract][Full Text] [Related]
2. Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation. Zhang X; Tanaka K; Yan J; Li J; Peng D; Jiang Y; Yang Z; Barton MC; Wen H; Shi X Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17284-9. PubMed ID: 24101509 [TBL] [Abstract][Full Text] [Related]
3. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins. Xu S; Zhong C; Zhang T; Ding J J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641 [TBL] [Abstract][Full Text] [Related]
4. Purification of Histone Lysine Methyltransferase SMYD2 and Co-Crystallization with a Target Peptide from Estrogen Receptor α. Jiang Y; Holcomb J; Spellmon N; Yang Z Methods Mol Biol; 2016; 1366():207-217. PubMed ID: 26585137 [TBL] [Abstract][Full Text] [Related]
5. A motif in HSP90 and P23 that links molecular chaperones to efficient estrogen receptor α methylation by the lysine methyltransferase SMYD2. Obermann WMJ J Biol Chem; 2018 Oct; 293(42):16479-16487. PubMed ID: 30190324 [TBL] [Abstract][Full Text] [Related]
6. Molecular Cloning and Purification of the Protein Lysine Methyltransferase SMYD2 and its Co-crystallization with a Target Peptide from Estrogen Receptor Alpha. Zhang Y; Yang Z Methods Mol Biol; 2022; 2418():345-362. PubMed ID: 35119674 [TBL] [Abstract][Full Text] [Related]
8. Conformational Dynamics of Lysine Methyltransferase Smyd2. Insights into the Different Substrate Crevice Characteristics of Smyd2 and Smyd3. Chandramouli B; Chillemi G J Chem Inf Model; 2016 Dec; 56(12):2467-2475. PubMed ID: 27959541 [TBL] [Abstract][Full Text] [Related]
9. Structure of human SMYD2 protein reveals the basis of p53 tumor suppressor methylation. Wang L; Li L; Zhang H; Luo X; Dai J; Zhou S; Gu J; Zhu J; Atadja P; Lu C; Li E; Zhao K J Biol Chem; 2011 Nov; 286(44):38725-38737. PubMed ID: 21880715 [TBL] [Abstract][Full Text] [Related]
10. Smyd2 conformational changes in response to p53 binding: role of the C-terminal domain. Chandramouli B; Melino G; Chillemi G Mol Oncol; 2019 Jun; 13(6):1450-1461. PubMed ID: 31069954 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates. Weirich S; Schuhmacher MK; Kudithipudi S; Lungu C; Ferguson AD; Jeltsch A Chembiochem; 2020 Jan; 21(1-2):256-264. PubMed ID: 31612581 [TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of human SET and MYND domain-containing protein 2 methyltransferase. Wu J; Cheung T; Grande C; Ferguson AD; Zhu X; Theriault K; Code E; Birr C; Keen N; Chen H Biochemistry; 2011 Jul; 50(29):6488-97. PubMed ID: 21678921 [TBL] [Abstract][Full Text] [Related]
13. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2. Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380 [TBL] [Abstract][Full Text] [Related]
14. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Abu-Farha M; Lambert JP; Al-Madhoun AS; Elisma F; Skerjanc IS; Figeys D Mol Cell Proteomics; 2008 Mar; 7(3):560-72. PubMed ID: 18065756 [TBL] [Abstract][Full Text] [Related]
15. Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain. Jiang Y; Sirinupong N; Brunzelle J; Yang Z PLoS One; 2011; 6(6):e21640. PubMed ID: 21738746 [TBL] [Abstract][Full Text] [Related]
16. Structural basis of substrate methylation and inhibition of SMYD2. Ferguson AD; Larsen NA; Howard T; Pollard H; Green I; Grande C; Cheung T; Garcia-Arenas R; Cowen S; Wu J; Godin R; Chen H; Keen N Structure; 2011 Sep; 19(9):1262-73. PubMed ID: 21782458 [TBL] [Abstract][Full Text] [Related]
17. Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function. Voelkel T; Andresen C; Unger A; Just S; Rottbauer W; Linke WA Biochim Biophys Acta; 2013 Apr; 1833(4):812-22. PubMed ID: 23047121 [TBL] [Abstract][Full Text] [Related]
18. Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics. Olsen JB; Cao XJ; Han B; Chen LH; Horvath A; Richardson TI; Campbell RM; Garcia BA; Nguyen H Mol Cell Proteomics; 2016 Mar; 15(3):892-905. PubMed ID: 26750096 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex. Brown MA; Sims RJ; Gottlieb PD; Tucker PW Mol Cancer; 2006 Jun; 5():26. PubMed ID: 16805913 [TBL] [Abstract][Full Text] [Related]
20. Discovery of substrates for a SET domain lysine methyltransferase predicted by multistate computational protein design. Lanouette S; Davey JA; Elisma F; Ning Z; Figeys D; Chica RA; Couture JF Structure; 2015 Jan; 23(1):206-215. PubMed ID: 25533488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]